Tuan Si
Senior Vice President | Drug Safety & Pharmacovigilance at Nuvalent, Inc. | Boston, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Tuan Si serves as the Senior Vice President of Clinical Safety & Pharmacovigilance at Nuvalent, Inc., where he leverages over two decades of extensive experience in the pharmaceutical industry to enhance drug safety and efficacy across various therapeutic areas. With a strong focus on oncology, Tuan is at the forefront of developing robust pharmacovigilance strategies that prioritize patient safety while navigating the complexities of clinical development. His expertise encompasses critical aspects of drug safety, including signal detection, evaluation, and comprehensive benefit-risk management, ensuring that Nuvalent's innovative therapies meet the highest regulatory standards and deliver meaningful outcomes for patients.
In his current role, Tuan leads key projects aimed at optimizing pharmacovigilance processes, fostering a culture of safety within the organization, and enhancing collaboration with regulatory bodies such as the FDA. His analytical skills and deep understanding of clinical development allow him to effectively assess the safety profiles of investigational drugs, particularly in challenging areas like CNS disorders, hematology/oncology, and rare diseases. Tuan’s commitment to direct patient care and his passion for advancing life sciences drive his efforts to implement best practices in Good Clinical Practice (GCP) and regulatory affairs.
Tuan embodies the philosophy of "Be humble; Stay curious," continuously seeking to expand his knowledge and adapt to the evolving landscape of drug development. His leadership not only inspires his team but also reinforces Nuvalent’s mission to bring safe and effective therapies to patients in need, ultimately contributing to the advancement of healthcare.
Senior Vice President | Drug Safety & Pharmacovigilance at Nuvalent, Inc. in July 2024 to Present
Senior Vice President | Drug Safety & Risk Management at Apellis Pharmaceuticals in December 2021 to August 2024
Vice President | Clinical Development & PV at Blueprint Medicines in March 2018 to December 2021
Vice President | Drug Safety & Pharmacovigilance at Akebia Therapeutics in November 2016 to March 2018
Executive Director | Clinical Development at Ionis Pharmaceuticals, Inc. in January 2016 to January 2016
Safety Science Leader at Genentech in January 2014 to January 2016
Global Safety Officer | Benefit & Risk Management, Boston, US at Biogen Idec Inc. in January 2011 to January 2014
Head Reg. Affairs & Pharmacovigilance, Germany at Biogen Idec Inc. in January 2008 to January 2011
Sr Medical Advisor | Drug Safety & Medical Affairs at GSK in January 2004 to January 2008
MD @ University Hospital of Psychiatry at Ludwig-Maximilians-Universität München in January 2003 to January 2004
MD @ University Hospital of Neurology at Department of Neurology, University of Heidelberg in January 2000 to January 2003
See more
See less
ICH
Safety surveillance
Risk Management
Early access program (EAP)
GVP
Safety database
Marketing Authorisation Application (MAA)
New Drug Application (NDA)
Rare Diseases
Oncology
Analytical Skills
Direct Patient Care
Patient Counseling
Leadership
Artificial Intelligence (AI) and Automation in PV
Biotechnology
Pharmaceutical Industry
Clinical Trials
Clinical Development
Lifesciences
Immunology
Biopharmaceuticals
Drug Development
Regulatory Affairs
Neurology
Pharmacovigilance
GCP
Infectious Diseases
FDA
Life Sciences
Drug Safety
Good Clinical Practice (GCP)
See more
See less
Discover more about Nuvalent, Inc.What is Tuan Si email address?
Email Tuan Si at [email protected] and [email protected]. This email is the most updated Tuan Si email found in 2026.
How to contact Tuan Si?
To contact Tuan Si send an email to [email protected] or [email protected]. (updated on October 30, 2024)
What company does Tuan Si work for?
Tuan Si works for Nuvalent, Inc.
What is Tuan Si's role at Nuvalent, Inc.?
Tuan Si is Senior Vice President | Drug Safety & Pharmacovigilance
What is Tuan Si's Phone Number?
Tuan Si's phone (413) ***-*222
What industry does Tuan Si work in?
Tuan Si works in the Biotechnology Research industry.
Tuan Si Email Addresses
Tuan Si Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Tuan Si
Talent Acquisition Partner at Perry Homes
Senior Affiliate Manager at Acceleration Partners
Sales Leader at AssuredPartners
Assistant to Vice President at Industrial and Commercial Bank of China, New York
Vehicle Exchange Specialist at Thompson Toyota
Painter at Mike the Painter
Senior Director, Brand Communications - North America Impact at McDonald's
Adjunct Lecturer at Mississippi State University
Partner at DSD Group
Instructor at Barbizon USA
Bankruptcy Supervisor at First Citizens Bank
Designer at Best Buy
Director, Commercial Notebook Product Management at HP
Corporate Director, Sales Programming & Communications at Hyatt Hotels Corporation
Director Of Marketing and Hospitality at Chick-fil-A S. Colorado & Yale
Payroll Services Manager at Populus Group
Business Administration and Reporting Analyst at Experitec Inc.
National Carrier Partnerships at Alight Solutions
CEO at ASync Solutions
Data Manager at Building Transparency
Show more
Show less